Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, complement 3 glomerulopathy, proteinuria, urinary system disorderRecruitingPhase 32026-07-13NCT04817618

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Albany Medical CenterAlbanyUnited States122
Baylor Scott and White ResearchTempleUnited States3
Brigham and Womens Hosp Harvard Med SchoolBostonUnited States5
Childrens Hospital ColoradoAuroraUnited States23
Col Uni Med Center New York PresbyNew YorkUnited States6
Georgia Nephrology Research InstLawrencevilleUnited States3
Hackensack Uni Medical CenterHackensackUnited States2
IN University School of MedIndianapolisUnited States1
Johns Hopkins HospitalBaltimoreUnited States135
Nicklaus Childrens HospitalMiamiUnited States4
University of Iowa Health CareIowa CityUnited States47
University of Iowa Health CareIowa CityUnited States3
University of WisconsinMadisonUnited States85